The post XRP Price Struggles Near $1.95 as Whale Inflows Hint at Exit Liquidity appeared on BitcoinEthereumNews.com. Since July 2025, the XRP price witnessed a The post XRP Price Struggles Near $1.95 as Whale Inflows Hint at Exit Liquidity appeared on BitcoinEthereumNews.com. Since July 2025, the XRP price witnessed a

XRP Price Struggles Near $1.95 as Whale Inflows Hint at Exit Liquidity

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
  • Since July 2025, the XRP price witnessed a steady downtrend, resonating within two converging trendlines of falling wedge patterns.
  • Large XRP transfers to Binance are dominated by holders controlling 100K–1M and 1M+ tokens
  • A bearish alignment between the key EMAs (20<50<100<200) indicates the path to least resistance is down.

XRP, the native cryptocurrency of the XRP Ledger, shows low volatility trading on weekends as its price stabilizes around $1.92. The buying pressure is still thin and the substantial exchange inflow from large investors highlights risk of prolonged correction. The technical chart also accentuates multiple resistance restriction XRP from sustained recovery.

XRP Faces Selling Pressure as Whale Deposits Surge on Binance 

Recent data on Binance shows large movements in XRP as transfers are mostly coming from holders who control between 100,000 to 1 million tokens and more than 1 million. These patterns are indicative of the major players, rather than everyday traders, moving assets onto trading platforms, often indicating the intention of offloading holdings.

Following sharp increases in these deposits, market trends show a consistent trend of declining peak values and troughs and indicate an imbalance where incoming supply exceeds purchasing interest. With no new strong buying activity, this kind of dynamic has resulted in slow declines with even moderate selling from big holders adding downward pressure.

Based on inflow intensity and price reactions, analyst PelinayPA highlights $1.82 to $1.87 as a major support zone where temporary halts and slight uptake have occurred in the past. Should deposit volumes continue to trade at heightened levels, additional slides could fall into the 1.50 to 1.66 dollar range. Overall, the visuals from this inflow tracking does not match with buildup for upward momentum.

Anticipation around possible XRP exchange-traded funds had fueled hopes for greater institutional participation and value growth through direct acquisitions. However, the response was in the form of an increase in token deposits on Binance. This suggests large accumulators, who took their positions first in the ETF frenzy, used their accumulator stashes to deliver exit liquidity. Essentially, these entities took advantage of the hype by directing sales at smaller market participants.

For this reason, efforts to push closer to $1.95 face push back, and iron the impression that positive changes are unlikely to occur while there are still high inflows.

XRP Price 2% Short From Key Resistance Challenge

In the last two weeks, the XRP price shows a brief pullback from $2.17 to $1.93, registering a loss of 12.34%. Consequently, the asset market cap plunged to $116.86 billion.

An analysis of the daily chart shows this downswing resonating strictly within two converging trendlines indicating the formation of falling wedge patterns. The chart setup is commonly supported at the end of downtrend as converging trendline hints diminishing bearish momentum.

With an intraday gain of 1.3%, the XRP price is heading close to the pattern’s resistance trendline at $2.2. The 20-day exponential moving average wavering close to this resistance indicates additional resistance against buyers.

If the crypto sellers continue to defend the overhead trendline, the coin price reverses lower and drives prolonged correction below the $2.

Therefore, for buyers to regain their control over this asset, the XRP price must breach the overhead trendline to initiate recovery momentum.

Also Read: Ethereum Finds Stability Above $2,700 Amid Macro Relief and Network Growth

Source: https://www.cryptonewsz.com/xrp-price-whale-inflows-hint-at-exit-liquidity/

Market Opportunity
XRP Logo
XRP Price(XRP)
$1.3656
$1.3656$1.3656
+0.67%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09